Showing 1 - 12 results of 12 for search 'N. Gunn', query time: 0.05s Refine Results
  1. 1
    Genetics of disease resistance in Arabidopsis to crop pathogens

    Genetics of disease resistance in Arabidopsis to crop pathogens by E.B. Holub, M. Tör, A. Cooper, P. Gordon, N. Gunn

    Published 2002-06-01
    Get full text
    Article
  2. 2
    Imaging Aβ and tau in early stage Alzheimer’s disease with [18F]AV45 and [18F]AV1451

    Imaging Aβ and tau in early stage Alzheimer’s disease with [18F]AV45 and [18F]AV1451 by Azadeh Firouzian, Alex Whittington, Graham E. Searle, Ivan Koychev, Giovanna Zamboni, Simon Lovestone, Roger N. Gunn, on behalf of the Deep and Frequent Phenotyping study team

    Published 2018-03-01
    Get full text
    Article
  3. 3
    NO<sub>2</sub> climatology in the northern subtropical region: diurnal, seasonal and interannual variability

    NO<sub>2</sub> climatology in the northern subtropical region: diurnal, seasonal and interannual variability by S. Rodríguez, O. Puentedura, M. Navarro, J. Iglesias, E. Cuevas, M. P. Chipperfield, I. Alonso, A. Richter, L. N. Gunn, M. Yela, M. Gil

    Published 2008-03-01
    Get full text
    Article
  4. 4
    Dopamine D2/D3 receptor abnormalities after traumatic brain injury and their relationship to post-traumatic depression

    Dopamine D2/D3 receptor abnormalities after traumatic brain injury and their relationship to post-traumatic depression by Amy E. Jolly, Vanessa Raymont, James H. Cole, Alex Whittington, Gregory Scott, Sara De Simoni, Graham Searle, Roger N. Gunn, David J. Sharp

    Published 2019-01-01
    Get full text
    Article
  5. 5
    Quantitative analysis of dynamic 18F-FDG PET/CT for measurement of lung inflammation

    Quantitative analysis of dynamic 18F-FDG PET/CT for measurement of lung inflammation by Christopher Coello, Marie Fisk, Divya Mohan, Frederick J. Wilson, Andrew P. Brown, Michael I. Polkey, Ian Wilkinson, Ruth Tal-Singer, Philip S. Murphy, Joseph Cheriyan, Roger N. Gunn

    Published 2017-05-01
    Get full text
    Article
  6. 6
    Comparison of four 11C-labeled PET ligands to quantify translocator protein 18 kDa (TSPO) in human brain: (R)-PK11195, PBR28, DPA-713, and ER176—based on recent publications that measured specific-to-non-displaceable ratios

    Comparison of four 11C-labeled PET ligands to quantify translocator protein 18 kDa (TSPO) in human brain: (R)-PK11195, PBR28, DPA-713, and ER176—based on recent publications that m... by Masahiro Fujita, Masato Kobayashi, Masamichi Ikawa, Roger N. Gunn, Eugenii A. Rabiner, David R. Owen, Sami S. Zoghbi, Mohamad B. Haskali, Sanjay Telu, Victor W. Pike, Robert B. Innis

    Published 2017-10-01
    Get full text
    Article
  7. 7
    First evaluation of PET-based human biodistribution and radiation dosimetry of 11C-BU99008, a tracer for imaging the imidazoline2 binding site

    First evaluation of PET-based human biodistribution and radiation dosimetry of 11C-BU99008, a tracer for imaging the imidazoline2 binding site by Ashwin V. Venkataraman, Nicholas Keat, James F. Myers, Samuel Turton, Inge Mick, Roger N. Gunn, Eugenii A. Rabiner, Jan Passchier, Christine A. Parker, Robin J. Tyacke, David J. Nutt

    Published 2018-07-01
    Get full text
    Article
  8. 8
    The relationship between synaptic density marker SV2A, glutamate and N-acetyl aspartate levels in healthy volunteers and schizophrenia: a multimodal PET and magnetic resonance spectroscopy brain imaging study

    The relationship between synaptic density marker SV2A, glutamate and N-acetyl aspartate levels in healthy volunteers and schizophrenia: a multimodal PET and magnetic resonance spec... by Ellis Chika Onwordi, Thomas Whitehurst, Ayla Mansur, Ben Statton, Alaine Berry, Marina Quinlan, Declan P. O’Regan, Maria Rogdaki, Tiago Reis Marques, Eugenii A. Rabiner, Roger N. Gunn, Anthony C. Vernon, Sridhar Natesan, Oliver D. Howes

    Published 2021-07-01
    Get full text
    Article
  9. 9
    Evaluation of Intraperitoneal [18F]-FDOPA Administration for Micro-PET Imaging in Mice and Assessment of the Effect of Subchronic Ketamine Dosing on Dopamine Synthesis Capacity

    Evaluation of Intraperitoneal [18F]-FDOPA Administration for Micro-PET Imaging in Mice and Assessment of the Effect of Subchronic Ketamine Dosing on Dopamine Synthesis Capacity by Els F. Halff, Sridhar Natesan, David R. Bonsall, Mattia Veronese, Anna Garcia-Hidalgo, Michelle Kokkinou, Sac-Pham Tang, Laura J. Riggall, Roger N. Gunn, Elaine E. Irvine, Dominic J. Withers, Lisa A. Wells, Oliver D. Howes

    Published 2022-01-01
    Get full text
    Article
  10. 10
    The relationship between cortical synaptic terminal density marker SV2A and glutamate early in the course of schizophrenia: a multimodal PET and MRS imaging study

    The relationship between cortical synaptic terminal density marker SV2A and glutamate early in the course of schizophrenia: a multimodal PET and MRS imaging study by Ellis Chika Onwordi, Thomas Whitehurst, Ekaterina Shatalina, Richard Carr, Ayla Mansur, Atheeshaan Arumuham, Martin Osugo, Tiago Reis Marques, Sameer Jauhar, Susham Gupta, Sofia Pappa, Ravi Mehrotra, Maja Ranger, Nikola Rahaman, Eugenii A. Rabiner, Roger N. Gunn, Sridhar Natesan, Oliver D. Howes

    Published 2025-03-01
    Get full text
    Article
  11. 11
    Synaptic density marker SV2A is reduced in schizophrenia patients and unaffected by antipsychotics in rats

    Synaptic density marker SV2A is reduced in schizophrenia patients and unaffected by antipsychotics in rats by Ellis Chika Onwordi, Els F. Halff, Thomas Whitehurst, Ayla Mansur, Marie-Caroline Cotel, Lisa Wells, Hannah Creeney, David Bonsall, Maria Rogdaki, Ekaterina Shatalina, Tiago Reis Marques, Eugenii A. Rabiner, Roger N. Gunn, Sridhar Natesan, Anthony C. Vernon, Oliver D. Howes

    Published 2020-01-01
    Get full text
    Article
  12. 12
    Discovery and clinical translation of ceperognastat, an O‐GlcNAcase (OGA) inhibitor, for the treatment of Alzheimer's disease

    Discovery and clinical translation of ceperognastat, an O‐GlcNAcase (OGA) inhibitor, for the treatment of Alzheimer's disease by William Kielbasa, Paul Goldsmith, Kevin B. Donnelly, Hugh N. Nuthall, Sergey Shcherbinin, Adam S. Fleisher, Jörg Hendle, Susan L. DuBois, Stephen L. Lowe, Feiyu Fred Zhang, Eric M. Woerly, Nicolas J.‐F. Dreyfus, David Evans, Jeremy Gilmore, Michele Mancini, Cristian C. Constantinescu, Roger N. Gunn, David S. Russell, Emily C. Collins, Miroslaw Brys, Michael L. Hutton, Dustin J. Mergott

    Published 2024-10-01
    Get full text
    Article

Search Tools: